Single-dose Crossover Study to Investigate Pharmacodynamics of AZD3199

PHASE2CompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

August 31, 2008

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions
AsthmaAirway Obstruction
Interventions
DRUG

AZD3199

Dry powder for inhalation, single dose

DRUG

Formoterol

Dry powder for inhalation, single dose

DRUG

Placebo

Dry powder for inhalation, single dose

Trial Locations (4)

Unknown

Research Site, Hvidovre

Research Site, Gothenburg

Research Site, Luleå

Research Site, Lund

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY